Transaction DateRecipientSharesTypePriceValue
22nd April 2020Arthur S Leibowitz18,564Grant/award etc.$0.00
22nd April 2020Timothy M. Cunningham27,847Grant/award etc.$0.00
22nd April 2020Gary S. Gillheeney88,181Grant/award etc.$0.00
22nd April 2020Wayne D Mackie18,564Grant/award etc.$0.00
22nd April 2020Lori Freedman26,918Grant/award etc.$0.00
22nd April 2020Patrick Bilbo34,035Grant/award etc.$0.00
22nd April 2020Antonio S. Montecalvo24,134Grant/award etc.$0.00
22nd April 2020Brian Grow32,488Grant/award etc.$0.00
22nd April 2020Joshua Alexander Tamaroff18,564Grant/award etc.$0.00
14th April 2020Brian Grow1,150Exercise of derivative$1.70$1,955.00
Organogenesis Holdings
Organogenesis Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Organogenesis Holdings, Inc. focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA.

Ticker: ORGO
Sector: Finance
Industry: Financial Conglomerates
SEC Central Index Key (CIK): 1661181
Employees: 835
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags